| Tag | Content |
|---|
EnhancerAtlas ID | HS127-12361 |
Organism | Homo sapiens |
Tissue/cell | Macrophage |
Coordinate | chr16:81031040-81033090 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ELK4 | MA0076.2 | chr16:81032120-81032131 | CCACTTCCGGC | + | 6.62 | | Gabpa | MA0062.2 | chr16:81032119-81032130 | TCCACTTCCGG | - | 6.32 | | ZBTB7A | MA0750.2 | chr16:81032119-81032132 | TCCACTTCCGGCT | - | 6.23 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_19609 | chr16:81030381-81031818 | CD4p_CD25-_Il17p_PMAstim_Th17 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr16 | 81031630 | 81031672 | | chr16 | 81031999 | 81032086 |
|
Enhancer Sequence | ATACAAGAGT GTCTTGAATA TGCATAAACA CATTTGTTAC GCCACCTAAA AGTATCTTCA 60
TAAGAACCTC TAGTGACCTT TATCAGAGAA GTATGTTAAC CATTAACCAG CTGTGTGACC 120
TCAGGCAAAT TATTAAACTT GAGACAAAGC TTTCTAATTC AATGATTTAA GATATTCAGC 180
AAGTTATCAG TAGTATTTAG AGAACCTACA GGTTCAGGAG AAAAGCAGGA AGCCTCAAGA 240
GACCCAATCC CGGAAATAAG CACTAAAGCA GAAACAGCTT GCTTATATTA ATAAGCCTGA 300
CTTCAAATAT TTTCGCCACA TTCTCGAAAT TAACAACTCA TTTTGTTCAG ATGAAATTCT 360
ACCAATTAAG AGAATTGGCT TATTATTTTA AAATGTATAT TATTCTGAGG GTTAAAGGGT 420
CATTAGTCTC ATATTAGTGT GAATATAGAT TGCTTTTTTC TTAATAGCTG GCTGAAAAAA 480
AAACTAAACA ATGAAATGAA ACCAGAAGTT GTGAAAAAAA ATTTCAAATT TAACAGATAT 540
AGCCATAAAA CTAATTATTA CACTGAAAAC ATGAAGCTGA AATCCCTGAA CTTAAGTTTA 600
ATTGGATCAT CCACAAGGTG GAAAATTAGC AGCCAAGGTC AAAGGAAAAA CATCATGGGC 660
AGCTGTTCTT TTTTTTTTTT TTTTTTTGTA GTCAGGGGTC TTGCTATGTT GCCCAGGCTG 720
GTTTCAAACT CCTGTCCTCA AGTGATCCTC AGCCTCCCAA AGTGTTGGGA CAGGCATGAG 780
CTACCGTGCC CCACCTGGGC TTAACCTACT CTAACTCAGA AATGATTACC AAAAGAAAGA 840
ACCGATTACC TGCTTTAATT TTTTTTAAAG TTCCAAATAG AAAACAGGAA CCAACCCATA 900
TCCATTAGGA TGGCTACTGC TGAAAAAAAA ACAGAAAATA ACAAACGCTA AAGAGGATGT 960
GGAGAAACTG AAACTCCTGC GCACTGTGGG CGGGCATGTA AACTGGGATA GCCACTGTGG 1020
AAACTGGTAT AGCAGTTCCT CAAAAAATTA AAAATGAAAT TACCATATGA TCCAACAATT 1080
CCACTTCCGG CTATATTTTC ATAAGAATTA AATGCAGGGT TTTGAAGAGA TATTTGAACA 1140
CCCATGTTCA CGGCATATTA TTCACAATAA TTAAAACATG GAAGCAACCC AAGAGTCCAA 1200
CAGACAATGG ATCAGCACAA TGTGGTATAT ACATACAATG GAATACTATT CAGCCTTAAA 1260
ATGGAAGGAA ATTCTGGCAT ATGCTACAAC ATGGATGAAA TGTGAGGACA TTCTGAATGA 1320
AATAAGCCAG TCAAAAAACA TATATATAGG GTTCAACATA CGCAAATCAA TAAATGTGAT 1380
TCTCCACACA AACAGAATTA AACACAAAAA CCATGTGATT ATCTCAATAG ATGCGAAAAA 1440
GCCTTTGATA AAATCCAACA TCCCTTCATG ATAAAAACCC TCAACAAACT AGGCACTGAA 1500
GAACATACCT CAAAATAAGA GCCATCTATG ACAAACTCAC AGCCAACATC ATACTGAACA 1560
GGCAAAAGAT GGAAGCATTT CCCTTGAGGA CCGGAACAAG GGAACAGGAT GCCCGCTCTC 1620
ACCACTCCTA TTCAACACAG TACTTATTTC CTAGCCAAAG CAATCAGTCA AGAGAAATAA 1680
AAGGCATCCG AATAAGAAAA GAAGTCAAAC TGTCTCTCTT CACTGACGAT ATGATTCTAT 1740
ACCCAGAAAA CCCTAAAGAC TCTGCCAAAT GACTTGAGTA GTTTCAGGAT ACAAGATCAA 1800
CATAGAAAAA TCAGTAGCAC GTCTATACAC TATAAGGTTC AACCTGAAAG CCAAATCAAG 1860
AATACAATCC CATTTTCAAT TGCCACCAAA AAAATAAAAT ACCCAGGAAT ACATCCAACC 1920
AAGGAGGTAA AAGATCTCTA CAGGAAGAAC TACAAAACAC TGCTGAAAGA AATCACAGAT 1980
GACACAAACA AATAGAAAAA CATTCCGTGC TCATGGATTG GGAGAATCAA TATCACTGAA 2040
ATGGCCATAT 2050
|
